Estuary Biotherapeutics vs Recursion
Which Healthcare AI tool is better in 2026?
Estuary Biotherapeutics
Charting a new course for patients with kidney disease by developing targeted gene therapies for ADPKD.
Recursion
Pioneering AI-driven solutions in drug discovery to radically improve lives.
Side-by-side
Recursion is the more established option (raised $500M); pricing is comparable on both sides.
| Metric | Estuary Biotherapeutics | Recursion |
|---|---|---|
| Taglinei | Charting a new course for patients with kidney disease by developing targeted gene therapies for ADPKD. | Pioneering AI-driven solutions in drug discovery to radically improve lives. |
| Foundedi | — | 2013🏆 |
| HQi | US | Salt Lake City, US |
| Employeesi | 11-50 | 501-1000🏆 |
| Neuron scorei | 0 | 67🏆 |
| Total fundingi | $103M | $500M🏆 |
| Latest roundi | seed · Oct 2026 | IPO · Apr 2021 |
| Valuationi | — | $2B🏆 |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Pricing not listed | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Estuary Biotherapeutics and Recursion.
| Capability | Estuary Biotherapeutics | Recursion |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Estuary Biotherapeutics
- Strong in AI Healthcare
🔵 Strengths of Recursion
- Has raised more capital ($500M vs $103M)
- Higher Neuron score (67 vs 0)
- Newer company (2013)
Which should you choose?
Choose Recursion if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Recursion if you want the most established option — it has raised $500M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Estuary Biotherapeutics vs Recursion — which is better?
It depends on your priority. Estuary Biotherapeutics is the leaner option; Recursion has broader feature depth. See the side-by-side table above.
Is Estuary Biotherapeutics cheaper than Recursion?
No — Recursion's cheapest paid plan is Enterprise · Contact sales, while Estuary Biotherapeutics's is Pricing not listed.
Do Estuary Biotherapeutics and Recursion offer free plans?
Estuary Biotherapeutics: Paid only. Recursion: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.